PI-9 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PI-9 Antibodies for advanced research in cellular biology. PI-9 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PI-9, or Protease Inhibitor 9, plays a crucial role in regulating apoptosis and immune responses by inhibiting caspases, which are essential for programmed cell death. Its importance is demonstrated in various pathological conditions, including cancer and autoimmune diseases, where dysregulation of apoptosis can lead to disease progression. Understanding the function of PI-9 is vital for developing therapeutic strategies aimed at modulating cell death pathways. PI-9 has emerged as a significant target in cancer research due to its role in tumor cell survival and resistance to therapy. Research has shown that PI-9 expression levels can serve as potential biomarkers for disease progression and treatment response. Investigating PI-9's regulatory mechanisms provides insights into cellular survival pathways and immune system function. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PI-9's role in health and disease.